PTSD Trial, Recruiting NCT07462312 Sponsor: NeuroBrave ltd. Condition: PTSD
Back to Ptsd

PTSD Trial, Recruiting

NCT07462312
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are male and aged 18 years or older
  • People who have been clinically diagnosed with Post-Traumatic Stress Disorder (PTSD) with mild to moderate-severe symptoms
  • People whose PTSD symptom score (measured using a standard tool called the PCL-5) is 60 or below at the screening stage
  • People whose PTSD is linked to a traumatic event that happened in the year 2000 or later
  • People who are eligible for rehabilitation services through the Ministry of Defense (MOD)
  • People who are able to use a smartphone and a wearable device (such as a fitness tracker)

Who may not be able to join:

  • People whose PTSD symptoms are above the moderate-severe range (a PCL-5 score above 60) or who need a higher level of clinical care
  • People experiencing acute psychiatric instability, including active thoughts of suicide or psychosis
  • People who are currently taking the medications Olanzapine (also known as Zyprexa) or Quetiapine (also known as Seroquel)
  • People with severe sleep problems, based on a score above 7 on a standard sleep assessment tool called the Insomnia Severity Index
  • People with severe difficulties in concentration or thinking that would prevent them from using digital biofeedback tools

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
NeuroBrave ltd.
Registry
ClinicalTrials.gov
Start date
15 September 2025
Est. completion
30 September 2026

Where this trial is recruiting

🇮🇱 Israel

Primary endpoints

Change in PTSD Symptom Severity (PCL-5 Total Score)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov